Department of Physiotherapy, Faculty of Allied Health Sciences, Thammasat University, Bangkok, Thailand -
Thammasat University Research Unit for Physical Therapy in Respiratory and Cardiovascular Systems, Thammasat University, Pathumthani, Thailand -
Eur J Phys Rehabil Med. 2022 Dec;58(6):838-844. doi: 10.23736/S1973-9087.22.07612-2. Epub 2022 Nov 23.
Sarcopenia is an age-related loss of muscle mass, decline in physical performance, and/or loss of muscle strength. Improving physical activity (PA) is associated with a reduced risk of sarcopenia. Additionally, the World Health Organization 2020 guidelines recommend 150 minutes/week of moderate-intensity or 75 minutes/week of vigorous PA plus resistance exercise twice a week. An increase in walking steps/day also enhances PA.
The study explored the benefits of a pedometer-based walking program plus a resistance exercise program in older adults with sarcopenia.
A randomized control trial.
In community dwelling.
Older individuals with sarcopenia.
Screening for sarcopenia was defined according to the Asian Working Group of Sarcopenia criteria in 2019, which is composed of the skeletal muscle mass index (SMI), muscle strength, and physical performance. Bioimpedance analysis, handgrip strength, and gait speed were measured for the SMI, muscle strength, and physical performance, respectively. to explore the effectiveness of a pedometer-based walking program plus TheraBand resistance exercise over 12 weeks. The intervention group was required to wear a pedometer and walk 7 500 steps/day for 5 days/week and perform the TheraBand resistance exercise twice a week, while the control group continued their routine daily activities. Respiratory muscle strength, functional capacity (i.e., 6-minute walk test), and PA were assessed before and after the 12-week program. To evaluate the benefits of the home-based walking program plus resistance exercise, two-way mixed ANOVAs were performed.
Sixty older individuals with sarcopenia aged ≥60 years were enrolled; however, a total of 57 older adults (28 in the invention group and 29 in the control group) completed the study. Inspiratory muscle strength, functional capacity, and PA increased between and within groups after the 12-week program (all P<0.05). Furthermore, muscle strength and physical performance improved in the intervention group after the 12-week program but not in the control group.
A pedometer-based intervention program with TheraBand resistance exercise could improve cardio-respiratory performance and PA among older Thai individuals with sarcopenia. Further study needs to consider type of exercise and dietary supplements.
Increasing the number of steps walked per day may reduce the risk of developing sarcopenia in older people.
肌少症是一种与年龄相关的肌肉质量下降、身体机能下降和/或肌肉力量丧失。增加身体活动(PA)与肌少症风险降低有关。此外,世界卫生组织 2020 年指南建议每周进行 150 分钟中等强度或 75 分钟剧烈强度的身体活动,外加每周两次的抗阻运动。每天增加步行步数也能提高 PA。
本研究旨在探讨计步器步行计划加抗阻运动方案对肌少症老年人的益处。
随机对照试验。
在社区居住环境中。
患有肌少症的老年人。
根据 2019 年亚洲肌少症工作组的标准,通过生物电阻抗分析、握力和步速来筛查肌少症,确定肌少症的筛查标准为骨骼肌指数(SMI)、肌肉力量和身体机能。分别测量 SMI、肌肉力量和身体机能的肌肉力量和身体机能。在 12 周内探索计步器步行计划加 Theraband 抗阻运动的效果。干预组要求佩戴计步器,每天行走 7500 步,每周 5 天,每周进行两次 Theraband 抗阻运动,而对照组则继续进行日常活动。在 12 周的方案前后评估呼吸肌力量、功能能力(即 6 分钟步行测试)和 PA。为了评估家庭步行计划加抗阻运动的益处,进行了双向混合方差分析。
共有 60 名年龄≥60 岁的老年人纳入研究,但只有 57 名老年人(干预组 28 名,对照组 29 名)完成了研究。干预组和对照组在 12 周方案后,吸气肌力量、功能能力和 PA 均有提高(均 P<0.05)。此外,干预组在 12 周方案后肌肉力量和身体机能有所改善,但对照组没有。
计步器加 Theraband 抗阻运动的干预方案可以提高泰国患有肌少症的老年人的心肺功能表现和 PA。进一步的研究需要考虑运动类型和膳食补充剂。
每天增加行走步数可能会降低老年人患肌少症的风险。